[
  {
    "ts": "2025-12-02T13:12:24+00:00",
    "headline": "Vaccine stocks brace for shock waves at this week’s ACIP meeting",
    "summary": "Investing.com -- Bernstein warned in a note Tuesday that “shock waves are expected at the ACIP meeting this week,” citing a series of unusual developments that could have implications for Merck, Pfizer and Moderna.",
    "url": "https://finance.yahoo.com/news/vaccine-stocks-brace-shock-waves-131224558.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "0f6df930-08e0-3ac1-b456-99e66c8e2b9b",
      "content": {
        "id": "0f6df930-08e0-3ac1-b456-99e66c8e2b9b",
        "contentType": "STORY",
        "title": "Vaccine stocks brace for shock waves at this week’s ACIP meeting",
        "description": "",
        "summary": "Investing.com -- Bernstein warned in a note Tuesday that “shock waves are expected at the ACIP meeting this week,” citing a series of unusual developments that could have implications for Merck, Pfizer and Moderna.",
        "pubDate": "2025-12-02T13:12:24Z",
        "displayTime": "2025-12-02T13:12:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vaccine-stocks-brace-shock-waves-131224558.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vaccine-stocks-brace-shock-waves-131224558.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T13:00:33+00:00",
    "headline": "How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint",
    "summary": "Shares of BridgeBio Pharma are nearing a record high as the small biotech company takes on drug behemoths Pfizer and Alnylam Pharmaceuticals.",
    "url": "https://www.investors.com/news/technology/bridgebio-pharma-stock-2025/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "50f6eaa5-3d4a-3073-b1e6-93e917c5b477",
      "content": {
        "id": "50f6eaa5-3d4a-3073-b1e6-93e917c5b477",
        "contentType": "STORY",
        "title": "How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint",
        "description": "",
        "summary": "Shares of BridgeBio Pharma are nearing a record high as the small biotech company takes on drug behemoths Pfizer and Alnylam Pharmaceuticals.",
        "pubDate": "2025-12-02T13:00:33Z",
        "displayTime": "2025-12-02T13:00:33Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/50f6eaa5-3d4a-3073-b1e6-93e917c5b477/how-bridgebio-a-top-4-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/2955ead9dc8e850a5670af24935a7409",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fkT3a4xn8jt3Ju9ETIFZLg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/2955ead9dc8e850a5670af24935a7409.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Mkh6j8BOJpzU5lS.Wb_9Pg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/2955ead9dc8e850a5670af24935a7409.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/bridgebio-pharma-stock-2025/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BBIO"
            },
            {
              "symbol": "NTLA"
            },
            {
              "symbol": "SRPT"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "ALNY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T13:00:11+00:00",
    "headline": "If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now?",
    "summary": "Pfizer Inc. (NYSE:PFE) is a global biopharmaceutical company that discovers, develops, manufactures, and markets medicines, vaccines, and healthcare products. It is set to report its Q4 2025 earnings on Feb. 3. Wall Street analysts expect the company ...",
    "url": "https://finance.yahoo.com/news/invested-10k-pfizer-stock-10-130011705.html",
    "source": "Benzinga",
    "provider": "yfinance",
    "raw": {
      "id": "30e98ceb-6471-37c3-86ba-e9d157d1587f",
      "content": {
        "id": "30e98ceb-6471-37c3-86ba-e9d157d1587f",
        "contentType": "STORY",
        "title": "If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now?",
        "description": "",
        "summary": "Pfizer Inc. (NYSE:PFE) is a global biopharmaceutical company that discovers, develops, manufactures, and markets medicines, vaccines, and healthcare products. It is set to report its Q4 2025 earnings on Feb. 3. Wall Street analysts expect the company ...",
        "pubDate": "2025-12-02T13:00:11Z",
        "displayTime": "2025-12-02T13:00:11Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/benzinga_79/fa3532eb93ad514ea305e9e6e5abdace",
          "originalWidth": 720,
          "originalHeight": 480,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rAIxnhe_Ag.QNcPniwLnyA--~B/aD00ODA7dz03MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/fa3532eb93ad514ea305e9e6e5abdace.cf.webp",
              "width": 720,
              "height": 480,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IzfHYqNZOR1MC3NiKITFFg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/fa3532eb93ad514ea305e9e6e5abdace.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Benzinga",
          "url": "https://www.benzinga.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/invested-10k-pfizer-stock-10-130011705.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/invested-10k-pfizer-stock-10-130011705.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T12:44:00+00:00",
    "headline": "2 Top Dividend Stocks to Buy Now and Hold For a Decade",
    "summary": "These healthcare leaders can make you money while you sleep.",
    "url": "https://www.fool.com/investing/2025/12/02/2-top-dividend-stocks-to-buy-now-and-hold-for-a-de/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "d90e8141-8f51-32aa-9059-f2faaa0c5699",
      "content": {
        "id": "d90e8141-8f51-32aa-9059-f2faaa0c5699",
        "contentType": "STORY",
        "title": "2 Top Dividend Stocks to Buy Now and Hold For a Decade",
        "description": "",
        "summary": "These healthcare leaders can make you money while you sleep.",
        "pubDate": "2025-12-02T12:44:00Z",
        "displayTime": "2025-12-02T12:44:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/c8d3fb7c29ed4859e417e1426ab25537",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Physician talking to patient.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3lKJdnQkUt3sk68B4mmnJA--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/c8d3fb7c29ed4859e417e1426ab25537.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eNkLc149UTYkoIjSo4yU1g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/c8d3fb7c29ed4859e417e1426ab25537.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/02/2-top-dividend-stocks-to-buy-now-and-hold-for-a-de/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-top-dividend-stocks-buy-124400414.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T14:00:05+00:00",
    "headline": "Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock",
    "summary": "Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finance.yahoo.com/news/know-beyond-why-pfizer-inc-140005544.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "13d10ff5-b908-3872-aa92-5d618f0b7bc7",
      "content": {
        "id": "13d10ff5-b908-3872-aa92-5d618f0b7bc7",
        "contentType": "STORY",
        "title": "Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock",
        "description": "",
        "summary": "Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.",
        "pubDate": "2025-12-02T14:00:05Z",
        "displayTime": "2025-12-02T14:00:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/023168c7ea091c342492be3899b280af",
          "originalWidth": 900,
          "originalHeight": 618,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AH29CN1G1bp_AgmMAtiHlQ--~B/aD02MTg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/023168c7ea091c342492be3899b280af.cf.webp",
              "width": 900,
              "height": 618,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xcYKn6Tda5Sy52WTJQhMtA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/023168c7ea091c342492be3899b280af.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/know-beyond-why-pfizer-inc-140005544.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/know-beyond-why-pfizer-inc-140005544.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T15:30:00+00:00",
    "headline": "Nanopharmaceuticals Research Report 2025: Market to Reach $104.58 Billion by 2030, Driven by Rising Chronic Disease Burden and Growing Investment in Regenerative Medicine and Nanotechnology Drugs",
    "summary": "The nanopharmaceuticals market presents opportunities in addressing chronic diseases through enhanced targeted therapies and bioavailability. Personalization in treatments, particularly in oncology, is a key trend. However, high R&D costs and regulatory hurdles pose challenges. Key players include Merck, Pfizer, and Novartis. Nanopharmaceuticals Market Nanopharmaceuticals Market Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The \"Nanopharmaceuticals Market - Global Industry Size, Share, Trends, Oppor",
    "url": "https://finance.yahoo.com/news/nanopharmaceuticals-research-report-2025-market-153000292.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "ddd41f85-4b4d-3bce-90c2-0f4cba5b16a2",
      "content": {
        "id": "ddd41f85-4b4d-3bce-90c2-0f4cba5b16a2",
        "contentType": "STORY",
        "title": "Nanopharmaceuticals Research Report 2025: Market to Reach $104.58 Billion by 2030, Driven by Rising Chronic Disease Burden and Growing Investment in Regenerative Medicine and Nanotechnology Drugs",
        "description": "",
        "summary": "The nanopharmaceuticals market presents opportunities in addressing chronic diseases through enhanced targeted therapies and bioavailability. Personalization in treatments, particularly in oncology, is a key trend. However, high R&D costs and regulatory hurdles pose challenges. Key players include Merck, Pfizer, and Novartis. Nanopharmaceuticals Market Nanopharmaceuticals Market Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The \"Nanopharmaceuticals Market - Global Industry Size, Share, Trends, Oppor",
        "pubDate": "2025-12-02T15:30:00Z",
        "displayTime": "2025-12-02T15:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/b223a5ddc062f0eb6d7821bb77d80756",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Nanopharmaceuticals Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qrKLm.Rj1pX387tgl8rMYQ--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b223a5ddc062f0eb6d7821bb77d80756.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NDLorc_s9i8YXneqzKgvow--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b223a5ddc062f0eb6d7821bb77d80756.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nanopharmaceuticals-research-report-2025-market-153000292.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nanopharmaceuticals-research-report-2025-market-153000292.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T14:40:00+00:00",
    "headline": "Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules",
    "summary": "Shares of vaccine makers slide as an internal FDA memo on vaccine safety and plans for stricter rules spark broad pressure across the overall industry.",
    "url": "https://finance.yahoo.com/news/vaccine-stocks-fall-fda-plans-144000603.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "9022f328-366e-3044-bdd3-26c2311190a8",
      "content": {
        "id": "9022f328-366e-3044-bdd3-26c2311190a8",
        "contentType": "STORY",
        "title": "Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules",
        "description": "",
        "summary": "Shares of vaccine makers slide as an internal FDA memo on vaccine safety and plans for stricter rules spark broad pressure across the overall industry.",
        "pubDate": "2025-12-02T14:40:00Z",
        "displayTime": "2025-12-02T14:40:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/bb18a3f978dd9c6e7e344c74d8d4468e",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ekclbrnZm9hqqdNHT70btw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/bb18a3f978dd9c6e7e344c74d8d4468e.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/b7SzKNzy6CHcgFEK4eV8YA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/bb18a3f978dd9c6e7e344c74d8d4468e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vaccine-stocks-fall-fda-plans-144000603.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vaccine-stocks-fall-fda-plans-144000603.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVAX"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "BNTX"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "PCVX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T15:24:00+00:00",
    "headline": "Pfizer's Cancer Drugs Deliver Growth Amid Competitive Pressure",
    "summary": "Pfizer's expanding oncology portfolio, rising sales of key therapies, and steady pipeline progress reinforce its long-term cancer strategy momentum.",
    "url": "https://finance.yahoo.com/news/pfizers-cancer-drugs-deliver-growth-152400012.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "d3e3d388-1171-33cf-b6f6-b2a7a6cf2f52",
      "content": {
        "id": "d3e3d388-1171-33cf-b6f6-b2a7a6cf2f52",
        "contentType": "STORY",
        "title": "Pfizer's Cancer Drugs Deliver Growth Amid Competitive Pressure",
        "description": "",
        "summary": "Pfizer's expanding oncology portfolio, rising sales of key therapies, and steady pipeline progress reinforce its long-term cancer strategy momentum.",
        "pubDate": "2025-12-02T15:24:00Z",
        "displayTime": "2025-12-02T15:24:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A9LQHlDmqgPJbKsotfjd8w--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o5.ym16dSp_UIlCHMRMZUw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizers-cancer-drugs-deliver-growth-152400012.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizers-cancer-drugs-deliver-growth-152400012.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T17:15:15+00:00",
    "headline": "Assessing Pfizer's (PFE) Valuation After Recent Share Price Rebound",
    "summary": "Pfizer (PFE) shares have shown some movement this week, drawing attention for investors evaluating the company’s current position and recent performance. The stock’s slight rebound over the past month is notable, particularly after a period of declines earlier this year. See our latest analysis for Pfizer. Pfizer’s share price has turned a corner after earlier weakness this year, with a modest 2.5% gain over the past month that points to emerging momentum. However, the long-term picture...",
    "url": "https://finance.yahoo.com/news/assessing-pfizers-pfe-valuation-recent-171515499.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "5cde670a-5d04-3b2a-ba2c-fdbebddfc5e5",
      "content": {
        "id": "5cde670a-5d04-3b2a-ba2c-fdbebddfc5e5",
        "contentType": "STORY",
        "title": "Assessing Pfizer's (PFE) Valuation After Recent Share Price Rebound",
        "description": "",
        "summary": "Pfizer (PFE) shares have shown some movement this week, drawing attention for investors evaluating the company’s current position and recent performance. The stock’s slight rebound over the past month is notable, particularly after a period of declines earlier this year. See our latest analysis for Pfizer. Pfizer’s share price has turned a corner after earlier weakness this year, with a modest 2.5% gain over the past month that points to emerging momentum. However, the long-term picture...",
        "pubDate": "2025-12-02T17:15:15Z",
        "displayTime": "2025-12-02T17:15:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/assessing-pfizers-pfe-valuation-recent-171515499.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/assessing-pfizers-pfe-valuation-recent-171515499.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T17:28:00+00:00",
    "headline": "LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website",
    "summary": "Eli Lilly trims Zepbound vial prices on LillyDirect, offering lower monthly costs for self-paying patients across multiple doses.",
    "url": "https://finance.yahoo.com/news/lly-lowers-prices-zepbound-vials-172800929.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "84c35a8a-137d-380d-bc99-e92e50b60d52",
      "content": {
        "id": "84c35a8a-137d-380d-bc99-e92e50b60d52",
        "contentType": "STORY",
        "title": "LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website",
        "description": "",
        "summary": "Eli Lilly trims Zepbound vial prices on LillyDirect, offering lower monthly costs for self-paying patients across multiple doses.",
        "pubDate": "2025-12-02T17:28:00Z",
        "displayTime": "2025-12-02T17:28:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MjuR.4zEKm0FgKsxK.lBKQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G.VCDKzJSEg_sv.1sSAJrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lly-lowers-prices-zepbound-vials-172800929.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lly-lowers-prices-zepbound-vials-172800929.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T17:11:00+00:00",
    "headline": "17 dividend-stock bargains from a value manager with a stellar track record",
    "summary": "John Buckingham, editor of the Prudent Speculator, reminds investors to be “willing to stomach volatility.”",
    "url": "https://www.marketwatch.com/story/17-dividend-stock-bargains-from-a-value-manager-with-a-stellar-track-record-6df0e310",
    "source": "MarketWatch",
    "provider": "yfinance",
    "raw": {
      "id": "d642e76b-c878-315f-9a6a-a546e9942704",
      "content": {
        "id": "d642e76b-c878-315f-9a6a-a546e9942704",
        "contentType": "STORY",
        "title": "17 dividend-stock bargains from a value manager with a stellar track record",
        "description": "",
        "summary": "John Buckingham, editor of the Prudent Speculator, reminds investors to be “willing to stomach volatility.”",
        "pubDate": "2025-12-02T17:11:00Z",
        "displayTime": "2025-12-02T17:11:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketwatch_hosted_869/43ab2bd14bad02245da2b360f11111fd",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t_y5A41ctIgC.cOCddoZ5A--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketwatch_hosted_869/43ab2bd14bad02245da2b360f11111fd.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Dnr08T2dlMbtr.XzuaBWlQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketwatch_hosted_869/43ab2bd14bad02245da2b360f11111fd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketWatch",
          "url": "http://www.marketwatch.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketwatch.com/story/17-dividend-stock-bargains-from-a-value-manager-with-a-stellar-track-record-6df0e310",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/17-dividend-stock-bargains-value-171100825.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]